What's happening at the Breakthrough Science Summit?
Next month, our award-winning reporters will host discussions about tackling drug pricing, diversity in clinical trials, what it took to develop an oral drug treatment for Covid-19, and much more.
Get Ticket
Program Spotlights
Take a glance at a few of the sessions we have planned, then get your ticket to be a part of them:
CRISPR at a crossroads
Last summer, researchers accomplished a first: the editing of genes inside living people to treat disease. A look at what happens next with Intellia Therapeutics executive vice president and chief scientific officer, Laura Sepp-Lorenzino, Ph.D.
Merck: What’s next for its research labs?
Over the past decade, Merck has delivered for patients and investors because of one drug: the cancer medicine Keytruda. Now, new R&D head Dean Li, M.D., Ph.D. lays out what’s next after some big wins and also some setbacks.
Biotech’s event horizon
When an idea for a new medicine emerges in academia, it’s time to form a company around it. But the negotiations between venture capitalists and the offices that guard intellectual property at universities can be fraught — and many good ideas never escape their gravity. A look at one of the great barriers to innovation.
The scientist as entrepreneur
The Covid pandemic gave Regeneron a chance to show what it could do, as its monoclonal antibody made the company famous outside the biotech industry. Now one of biotech’s most outspoken executives, George Yancopoulos, M.D., Ph.D., lays out the plans that he says will keep the company ahead of the curve.
GET TICKET
Ticket Benefits
With a Viewer Pass, you'll unlock the virtual program, plus access to recordings of every main-stage session, and networking opportunities via our event platform.
For the chance to join us live instead in New York, apply for the Attendee Pass upgrade at checkout. If approved, you'll participate in the day in-person, and unlock a networking reception with fellow attendees and the STAT team. Learn more at statnews.com/summit.
GET TICKET
Questions?
Send us an email at summit@statnews.com.
No comments